openPR Logo
Press release

Attention Deficit Hyperactivity Disorder (ADHD) Market size reached US$16.23 billion in 2024 and is projected to reach US$27.04 billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033

07-03-2025 01:40 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research LLP

Global Attention Deficit Hyperactivity Disorder Market

Global Attention Deficit Hyperactivity Disorder Market

The Global Attention Deficit Hyperactivity Disorder Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/attention-deficit-hyperactivity-disorder-adhd-market?jd

Global Attention Deficit Hyperactivity Disorder Market Landscape Analysis:
The Global Attention Deficit Hyperactivity Disorder (ADHD) Market includes a range of pharmacological and non-pharmacological treatments aimed at managing symptoms such as inattention, hyperactivity, and impulsivity.

Global Attention Deficit Hyperactivity Disorder Market Shifting Industry Trends and Market Potential

In July 2025, Supernus Pharmaceuticals acquired Sage Therapeutics in a $561 million deal (potential value ~$795 million with milestones), strengthening its ADHD and broader CNS portfolio following Sage's setbacks.

* Rising Diagnosis Rates Among Children and Adults: Increased awareness and improved screening tools are boosting early ADHD diagnoses globally.
* Growing Demand for Non-Stimulant Therapies: Safety concerns around traditional stimulants are driving demand for alternatives like atomoxetine and viloxazine.
* Expansion of Digital Therapeutics: App-based behavioral interventions and telehealth platforms are becoming integral to ADHD care.
* Improved Access to Mental Health Services: Public health campaigns and insurance coverage expansion are improving treatment reach, especially in emerging economies.

Strategic Players Driving the Global Attention Deficit Hyperactivity Disorder Market Forward:

Key players are Pfizer Inc., Takeda Pharmaceutical Company Limited, Novartis AG, Eli Lilly and Company, Lupin, Mallinckrodt, Hisamitsu Pharmaceutical Co., Inc., Camber Pharmaceuticals, Inc., Collegium Pharmaceutical, Inc., and Supernus Pharmaceuticals, Inc.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/attention-deficit-hyperactivity-disorder-adhd-market?jd

Research Methodology:
The Global Attention Deficit Hyperactivity Disorder Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Global Attention Deficit Hyperactivity Disorder Market:

By Type (Predominantly Inattentive Presentation, Predominantly Hyperactive/Impulsive Presentation, Combined Presentation), By Drug Type (Stimulants, Non-stimulants), By Age Group (Pediatric, Adults, and Geriatrics).

Regional Analysis for Global Attention Deficit Hyperactivity Disorder Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=attention-deficit-hyperactivity-disorder-adhd-market?jd

Most Frequently Asked Questions in the Global Attention Deficit Hyperactivity Disorder Market Research Industry:

⇥ Who leads the Global Attention Deficit Hyperactivity Disorder Market and what's their competitive positioning regarding capacity, performance, and profitability?
⇥ What growth opportunities and market challenges do Global Attention Deficit Hyperactivity Disorder Market vendors face?
⇥ Which segments show the highest growth potential and market share distribution?
⇥ What factors are driving or limiting Global Attention Deficit Hyperactivity Disorder Market growth?
⇥ What are the dominant sales and distribution strategies in the Global Attention Deficit Hyperactivity Disorder Market?

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Attention Deficit Hyperactivity Disorder (ADHD) Market size reached US$16.23 billion in 2024 and is projected to reach US$27.04 billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033 here

News-ID: 4091246 • Views:

More Releases from DataM Intelligence 4Market Research LLP

United States Exocrine Pancreatic Insufficiency Treatment Market 2024-2031: Comprehensive Analysis of Pancreatic Enzyme Replacement Therapy, Nutritional Management, Emerging Therapies, and Strategic Growth Opportunities
United States Exocrine Pancreatic Insufficiency Treatment Market 2024-2031: Comp …
The Global Exocrine Pancreatic Insufficiency Treatment Market reached US$ 3.30 billion in 2023 and is expected to reach US$ 5.37 billion by 2031, growing at a CAGR of 6.4% during the forecast period 2024-2031. Exocrine Pancreatic Insufficiency (EPI) is a condition where the pancreas fails to produce sufficient digestive enzymes, leading to malabsorption, nutrient deficiencies, and gastrointestinal issues. Treatments primarily involve pancreatic enzyme replacement therapy (PERT), dietary modifications, and adjunctive nutritional
Herpes Labialis Drugs Market 2024-2031: Comprehensive Analysis of Antiviral Therapeutics, Topical and Oral Formulations, Emerging Therapies, and Strategic Market Opportunities | GlaxoSmithKline Pharmaceuticals, Bauch Health Inc., Novartis AG
Herpes Labialis Drugs Market 2024-2031: Comprehensive Analysis of Antiviral Ther …
The global herpes labialis drugs market reached US$ 1.16 billion in 2023 and is expected to reach US$ 1.7 billion by 2031 growing with a CAGR of 4.8% during the forecast period 2024-2031. Herpes labialis, commonly known as cold sores, is caused by the Herpes Simplex Virus-1 (HSV-1). Treatment options include antiviral drugs such as acyclovir, valacyclovir, famciclovir, and topical formulations, which help reduce symptoms, accelerate healing, and prevent recurrence. The
United States Chronic Inflammatory Demyelinating Polyneuropathy Market 2024-2031: In-Depth Analysis of Immunoglobulin Therapy, Corticosteroids, Plasma Exchange, and Emerging Biologics | Top Companies are Grifols, Baxter, Kedrion S.p.A
United States Chronic Inflammatory Demyelinating Polyneuropathy Market 2024-2031 …
Chronic Inflammatory Demyelinating Polyneuropathy Market is valued at a significant CAGR during the forecast period (2024-2031). Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder that leads to progressive weakness, numbness, and sensory impairment in the limbs. Current treatments include corticosteroids, intravenous immunoglobulin (IVIg), plasma exchange (plasmapheresis), and emerging biologics. The market is expanding due to increasing disease awareness, advances in therapeutic options, early diagnosis, and growing adoption of patient-centric
United States Varicella Zoster Infections Treatment Market 2024-2031: In-Depth Analysis of Antivirals, Vaccines, Pain Management Therapies, and Emerging Therapeutic Innovations | Bausch Health Companies Inc., LNHC, Inc., GSK plc.
United States Varicella Zoster Infections Treatment Market 2024-2031: In-Depth A …
Global Varicella Zoster Infections Treatment Market reached US$ 1,799.42 million in 2023 and is expected to reach US$ 2,523.90 million by 2031, growing at a CAGR of 4.3% during the forecast period 2024-2031. Varicella Zoster Virus (HHV-3) causes chickenpox (varicella) and shingles (herpes zoster). Treatments include antiviral drugs (acyclovir, valacyclovir, famciclovir), vaccines, and pain management therapies to prevent complications and manage symptoms. The market is growing due to increasing prevalence of

All 5 Releases


More Releases for Attention

Attention! chilliapple becomes Laravel certified company
chilliapple is a leading web and app development agency in the UK that has been operating since 2008. With a large team of in-house consultants, designers, developers, and QA analysts, the agency specialises in a range of services. Whether you are looking for bespoke software development or updating existing code, they can provide you with innovative solutions. They specialise in building online stores on several platforms like Magento, Shopify, PrestaShop,
Driver Attention Monitor Market Research Report 2023
Driver Attention Monitor Market Driver Attention Monitor is a vehicle safety system first introduced by Toyota in 2006 for its and Lexus latest models. Driver Attention Monitor can detect distracted and drowsy drivers by accurately measuring eye and head position, driver attention and fatigue. The system's functions co-operate with the Pre-Collision System (PCS). The system uses infrared sensors to monitor driver attentiveness. Specifically, the Driver Attention Monitor includes a CCD camera
Attention-bias Modification Treatment App (ABMT)
Global Attention-bias Modification Treatment App Market Research Report is a resource, which provides current as well as upcoming technical and financial details of the industry to 2027. This report gives you so important and essentials data of Market size, share, trends, Growth, applications, forecast and cost analysis. Delivery development in North America, China, Europe, and South East Asia, Japan as well as in the Globe. The report proves to be indispensable when
Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market : A Market Surv …
Attention deficit hyperactivity disorder also known as hyperkinetic disorder/ neuropsychiatric disorder is one of the most common brain disorder characterized by symptoms of hyperactivity, inattention, and impulsivity. It is commonly observed in children above 12years age as compared to older population. The exact cause of the Attention Deficit Hyperactivity Disorder (ADHD) is not clear but, expected to be resulted due to improper functioning of the nervous system that led to
Mining Industry Safety Attracts More Attention
A survey made on Wednesday by industrial software company Ventyx, a subsidiary of ABB, shows that mining industry safety is one of the three top concerns by mining executives, including employee safety, managing capital projects and maximising production effectiveness. This study makes the mining safety on the top position in mining industry. The 2012 Worldwide Mining Survey analyzed new trends and shifting attitudes around workforces, capital investments and technology and
ATTENTION EARTH!
It’s the year 2013, if you’re reading this Earth has shockingly survived the Mayan prediction and prophetic date of December 21st, 2012. Since this is being written in the past, it’s not certain what has happened to humankind. Did Earth collide with planet X? Or was the cataclysm of 2012 a positive physical and/or spiritual transformation for humanity. Be as it may, hopefully this day will mark the beginning of